HR Execs on the Move

BOMA Greater Little Rock

www.practice-plus.com

 
BOMA Greater Little Rock is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Mercy and Truth

Mercy and Truth Medical Missions is a non-profit organization that provides healthcare to the underserved people of the Kansas City community and world through Christian service.

Thriveworks

At Thriveworks, we believe that everyone can benefit from counseling or coaching with a skilled and caring professional. That`s why Thriveworks was founded—to help persons seeking counseling or coaching gain access to truly exceptional providers. Providers with a passion for helping each client make meaningful and extraordinary advances in his/her life, career, relationships, and happiness. We`re extremely selective about the counselors, psychologists, coaches, and psychiatrists that bear the “Thriveworks” name. Contact us to learn how a partnership with a caring and experienced counselor or coach can help you.

Ride Away Equipment Corp

Here at Ride Away, we offer a competitive benefits package for you and your loved ones. Here is a list of the benefits that Ride Away currently offers: Medical/Dental Insurance Vision Insurance Flex Spending Account (both medical and dependent care)

Osso VR

Osso VR is an award winning VR surgical and medical device training platform. The company is made up of practicing clinicians, professional VR developers and medtech industry veterans. We specialize in hyper-realistic, haptic-enhanced, hands-on interactivity and design.

HedgePath Pharmaceuticals

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. The Company may also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. We are focused on the development of therapies for more than one type of cancer, with initial emphasis in the U.S. market, based upon repurposing the currently marketed antifungal drug itraconazole for new indications in oncology.